CytoDyn Inc. (CYDY)
Data as of , from SEC Form 4 filings.
See up to 3 months of CYDY. The 7-day demo opens the 1M and 3M ranges and puts CYDY on your watchlist.
Start 7-day demoLatest CYDY insider trades
About CytoDyn Inc. (CYDY)
CYDY Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 1 | 2,500,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CYDY insider transactions (Form 4)
1717 Form 4 filings on record, the earliest from Oct 30, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Robert E. Hoffman - Officer | Grant or award | Non-qualified stock option (right to buy) | 2,500,000 footnote F1 | $0.00 | - | |
| ||||||
| Tanya Durkee Urbach - Director | Grant or award | Non-qualified stock option (right to buy) | 574,385 footnote F1 | $0.00 | - | |
| ||||||
| Stephen M. Simes - Director | Grant or award | Non-qualified stock option (right to buy) | 574,385 footnote F1 | $0.00 | - | |
| ||||||
| Lishomwa C. Ndhlovu - Director | Grant or award | Non-qualified stock option (right to buy) | 574,385 footnote F1 | $0.00 | - | |
| ||||||
| Jacob P. Lalezari - Officer | Grant or award | Non-qualified stock option (right to buy) | 4,874,691 footnote F1 | $0.00 | - | |
| ||||||
| Robert E. Hoffman - Officer | Grant or award | Non-qualified stock option (right to buy) | 4,874,691 footnote F1 | $0.00 | - | |
| ||||||
| Ryan Dunlap - Director | Grant or award | Non-qualified stock option (right to buy) | 574,385 footnote F1 | $0.00 | - | |
| ||||||
| Karen J. Brunke - Director | Grant or award | Non-qualified stock option (right to buy) | 574,385 footnote F1 | $0.00 | - | |
| ||||||
| Tyler Blok - Officer | Grant or award | Non-qualified stock option (right to buy) | 3,249,794 footnote F1 | $0.00 | - | |
| ||||||
| Robert E. Hoffman - Officer | Grant or award | Non-qualified stock option (right to buy) | 1,000,000 | $0.00 | - | |
| Tanya Durkee Urbach - Director | Grant or award | Non-qualified stock option (right to buy) | 800,000 | $0.00 | - | |
| Stephen M. Simes - Director | Grant or award | Non-qualified stock option (right to buy) | 800,000 | $0.00 | - | |
| Lishomwa C. Ndhlovu - Director | Grant or award | Non-qualified stock option (right to buy) | 800,000 | $0.00 | - | |
| Jacob P. Lalezari - Officer | Grant or award | Non-qualified stock option (right to buy) | 3,000,000 | $0.00 | - | |
| Ryan Dunlap - Director | Grant or award | Non-qualified stock option (right to buy) | 800,000 | $0.00 | - | |
| Karen J. Brunke - Director | Grant or award | Non-qualified stock option (right to buy) | 800,000 | $0.00 | - | |
| Tyler Blok - Officer | Grant or award | Non-qualified stock option (right to buy) | 1,250,000 | $0.00 | - | |
Item 5.02, 7.01, 9.01
Item 7.01, 9.01
Item 1.01
Item 3.02
CYDY insider trading FAQ
What is the latest insider trade for CYDY?
CytoDyn Inc. (CYDY) had 1 insider filing in the last 90 days, with the most recent on 21 October 2026. The full record for CYDY runs to 17 Form 4 filings, the earliest from 30 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CYDY stock?
No insider purchases of CYDY were filed in the last 90 days.
How many insiders are selling CYDY stock?
No insider sales of CYDY were filed in the last 90 days.
Where can I see CYDY SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CYDY Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Robert E. Hoffman view on EDGAR
- - Tanya Durkee Urbach view on EDGAR
- - Stephen M. Simes view on EDGAR
- - Lishomwa C. Ndhlovu view on EDGAR
- - Jacob P. Lalezari view on EDGAR
- - Robert E. Hoffman view on EDGAR
- - Ryan Dunlap view on EDGAR
- - Karen J. Brunke view on EDGAR
- - Tyler Blok view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where CYDY's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CYDY with a 7-day demo
- CYDY on your watchlist
- Every CYDY Form 4 filing on record
- Up to 3 months of CYDY price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
